Skip to main content

VEGF Antibodies

VEGF antibodies are used to treat colon cancer, lung cancer, renal cancer, brain tumors, thyroid cancer, macular degeneration, and vitreomacular adhesion. They work by slowing down cancer cell growth to prevent it from spreading.

Why are vegf antibodies prescribed?

  1. Lung Cancer (13%)
  2. Renal Cancer (13%)
  3. Colon Cancer (13%)
  4. Cervical Cancer (13%)
  5. Macular Degeneration (13%)
  6. Stomach Cancer (13%)
  7. Brain Tumor (13%)
  8. Ovarian Cancer (13%)

Key takeaways

VEGF antibodies are used to treat certain types of cancer. Some VEGF antibodies have other uses, such as treating certain eye conditions like age-related macular degeneration (AMD), diabetic retinopathy, and macular edema. These medications work by blocking vascular endothelial growth factor (VEGF), a protein that promotes the growth of new blood vessels. It can help slow the progression of these medical conditions. VEGF antibodies are typically available as injections through the vein. Examples include Avastin (bevacizumab), Lucentis (ranibizumab), and Cyramza (ramucirumab). VEGF antibodies for eye conditions, such as Eylea (aflibercept), are injections given into the eye. You can discuss with your prescriber to determine the best option for your condition.

Prices for popular VEGF Antibodies medications
Viewing 19 of 19 medications
vial icon

Eylea HD

as low as$3
AFLIBERCEPT treats eye conditions, such as macular degeneration, macular edema, and retinopathy. It works by slowing the growth of abnormal new blood vessels in the eye. It also reduces the amount of fluid that leaks from these blood vessels. This helps maintain vision.
vial icon

Alymsys

as low as$178
Alymsys (bevacizumab-maly) is used to treat colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, cervical cancer and ovarian cancer. Alymsys is a biosimilar for avastin (bevacizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Alymsys may be covered by your Medicare or insurance plan.
vial icon

Vegzelma

as low as$655
Vegzelma (bevacizumab-adcd) is used to treat colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, cervical cancer and ovarian cancer. Vegzelma is a biosimilar for avastin (bevacizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Vegzelma may be covered by your Medicare or insurance plan.
vial icon

Cimerli

as low as$788
Cimerli (ranibizumab-eqrn) is used to treat macular degeneration. Cimerli is a biosimilar for lucentis (ranibizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Cimerli may be covered by your Medicare or insurance plan.
vial icon

Byooviz

as low as$1,121
Byooviz (ranibizumab-nuna) is used to treat macular degeneration. Byooviz is a biosimilar for lucentis (ranibizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Byooviz may be covered by your Medicare or insurance plan.
package icon

Pavblu

as low as$1,640
Pavblu is part of the VEGF Antibodies class and treats Macular Degeneration. VEGF antibodies are used to treat colon cancer, lung cancer, renal cancer, brain tumors, thyroid cancer, macular degeneration, and vitreomacular adhesion. They work by slowing down cancer cell growth to prevent it from spreading. Pavblu is only available as a brand name drug.
vial icon

Zirabev

as low as$3,529
Zirabev (bevacizumab-bvzr) is used to treat colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, cervical cancer and ovarian cancer. Zirabev is a biosimilar for avastin (bevacizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Zirabev may be covered by your Medicare or insurance plan.
vial icon

Mvasi

as low as$6,685
Mvasi (bevacizumab-awwb) is used to treat colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, cervical cancer and ovarian cancer. Mvasi is a biosimilar for avastin (bevacizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Mvasi may be covered by your Medicare or insurance plan.
Vabysmo (faricimab) is used to treat macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion. There are currently no generic alternatives to Vabysmo. It may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.
vial icon

Beovu

as low as$35,416
BROLUCIZUMAB treats macular degeneration and macular edema. It works by slowing the growth of abnormal new blood vessels in the eye. It also reduces the amount of fluid that leaks from these blood vessels. This helps maintain vision. It is a monoclonal antibody.
RANIBIZUMAB treats eye conditions, such as macular degeneration, macular edema, and retinopathy. It works by slowing the growth of abnormal new blood vessels in the eye. It also reduces the amount of fluid that leaks from these blood vessels. This helps maintain vision. It is a monoclonal antibody.
Avastin (bevacizumab) is used to treat colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, cervical cancer and ovarian cancer. Avastin is also available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Avastin is a VEGF antibody which works to slow down cancer cell growth to prevent spread. Avastin is avalible as a 4ml and 16ml vial. It is covered by some medicare and insurance plans.
Avzivi is only available as a brand name drug.
RAMUCIRUMAB treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. It is a monoclonal antibody.
AFLIBERCEPT treats eye conditions, such as macular degeneration, macular edema, and retinopathy. It works by slowing the growth of abnormal new blood vessels in the eye. It also reduces the amount of fluid that leaks from these blood vessels. This helps maintain vision.
Jobevne is part of the VEGF Antibodies class and treats Lung Cancer, Renal Cancer, Colon Cancer and other conditions. VEGF antibodies are used to treat colon cancer, lung cancer, renal cancer, brain tumors, thyroid cancer, macular degeneration, and vitreomacular adhesion. They work by slowing down cancer cell growth to prevent it from spreading. Jobevne is only available as a brand name drug.
Lucentis (ranibizumab) is used to treat macular degeneration. Lucentis is also available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. The currently approved biosimliars for Lucentis are cimerli (ranibizumab-eqrn) and byooviz (ranibizumab-nuna). Lucentis may be covered by your Medicare or insurance plan.
Opuviz is only available as a brand name drug.
ZIV-AFLIBERCEPT treats colorectal cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

Latest Articles

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.